<?xml version="1.0" encoding="UTF-8"?>
<p id="p0229" num="0229" sourceFile="EP 1326865B1.xml">The title compound was prepared using the procedure described in Example 1, Step 3 replacing with methyl 8-hydroxy-1,6-naphthyridine-7-carboxylate with methyl 5-chloro-8-[(4-methoxybenzyl)oxy]-1,6-naphthyridine-7-carboxylate from Step 4..
  <br/>
  <sup>1</sup>H NMR (CDCl
  <sub>3</sub>, 400MHz) δ 13.13 (1H, s), 9.25 (1H, d, 
  <i>J</i>=4.2Hz), 8.61 (1H,d, 
  <i>J</i>=8.5 Hz), 8.23 (1H, brs), 7.77 (1H, dd, 
  <i>J</i>=8.5 and 4.2 Hz), 7.35-7.20 (3H, m), 4.65 (2H, d, 
  <i>J</i>=6.4 Hz) ppm.
  <br/>
  <!-- EPO <DP n="197"> -->FAB MS calcd for C
  <sub>16</sub>H
  <sub>10</sub>N
  <sub>3</sub>O
  <sub>2</sub> Cl
  <sub>3</sub> 383 (MH
  <sup>+</sup>), found 383.
</p>
